A proven pathway waiting for funding

50 patients treated with >260 doses of their own personalized ASO in just six years. A >90% success rate. And an excellent safety and tolerability record.

n-Lorem has developed not only the science, but the regulatory pathway for rapidly bringing life-changing treatments to patients with nano-rare and devastating diseases.